Evidence map›Paper›PMID 31638890›Full record

ArticleBMC genomics2019

A framework for TRIM21-mediated protein depletion in early mouse embryos: recapitulation of Tead4 null phenotype over three days.

Steffen Israel, Ellen Casser, Hannes C A Drexler, Georg Fuellen, Michele Boiani

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Targeted Degradation of Mouse Embryo Proteins Using Trim-Away.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Review
  4. Retrotransposon renaissance in early embryos.Trends in genetics : TIG · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Targeted protein degradation in mammalian cells: A promising avenue toward future.Computational and structural biotechnology journal · 2022
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Steffen IsraelMax Planck Institute for Molecular Biomedicine, Roentgenstrasse 20, 48149, Muenster, Germany.
Ellen CasserMax Planck Institute for Molecular Biomedicine, Roentgenstrasse 20, 48149, Muenster, Germany.
Hannes C A DrexlerMax Planck Institute for Molecular Biomedicine, Roentgenstrasse 20, 48149, Muenster, Germany.
Georg FuellenRostock University Medical Center, Institute for Biostatistics and Informatics in Medicine and Aging Research (IBIMA), Ernst-Heydemann-Strasse 8, 18057, Rostock, Germany.
Michele BoianiMax Planck Institute for Molecular Biomedicine, Roentgenstrasse 20, 48149, Muenster, Germany. mboiani@mpi-muenster.mpg.de.ORCID http://orcid.org/0000-0003-2765-2781
Max Planck Institute for Molecular Biomedicine · DEUniversity of Rostock · DE

Funding

Deutsche Forschungsgemeinschaft DFG BO-2540/4-3Deutsche Forschungsgemeinschaft DFG FU-583/5-1
6 · The paper itself

Abstract

backgroundWhile DNA and RNA methods are routine to disrupt the expression of specific genes, complete understanding of developmental processes requires also protein methods, because: oocytes and early embryos accumulate proteins and these are not directly affected by DNA and RNA methods. When proteins in the oocyte encounter a specific antibody and the TRIpartite Motiv-containing 21 (TRIM21) ubiquitin-protein ligase, they can be committed to degradation in the proteasome, producing a transient functional knock-out that reveals the role of the protein. However, there are doubts about whether this targeted proteolysis could be successfully used to study mammalian development, because duration of the transient effect is unknown, and also because amounts of reagents delivered must be adequate in relation to the amount of target protein, which is unknown, too.

resultsWe show that the mouse egg contains up to 1E-02 picomoles/protein, as estimated by mass spectrometry using the intensity-based absolute quantification (iBAQ) algorithm. However, the egg can only accommodate ≈1E-04 picomoles of antibody or TRIM21 without incurring toxic effects. Within this framework, we demonstrate that TRIM21-mediated protein depletion efficiently disrupts the embryonic process of trophectoderm formation, which critically depends on the TEA domain family member 4 (Tead4) gene. TEAD4 depletion starting at the 1-cell stage lasts for 3 days prior to a return of gene and protein expression to baseline. This time period is long enough to result in a phenotype entirely consistent with that of the published null mutation and RNA interference studies: significant underexpression of trophectodermal genes Cdx2 and Gata3 and strongly impaired ability of embryos to cavitate and implant in the uterus. Omics data are available via ProteomeXchange (PXD012613) and GEO (GSE124844).

conclusionsTRIM21-mediated protein depletion can be an effective means to disrupt gene function in mouse development, provided the target gene is chosen carefully and the method is tuned accurately. The knowledge gathered in this study provides the basic know-how (prerequisites, requirements, limitations) to expedite the protein depletion of other genes besides Tead4.

Indexed as

AnimalsBlastocystCDX2 Transcription FactorDNA-Binding ProteinsEmbryo, MammalianEmbryonic DevelopmentEmbryo TransferFemaleGene Expression ProfilingMiceMicroinjectionsMuscle ProteinsOocytesPhenotypeProteolysisProteomeCdx2 protein, mouseCDX2 Transcription FactorDNA-Binding ProteinsMuscle ProteinsProteomeRNA, MessengerTead4 protein, mouseTEA Domain Transcription FactorsTranscription FactorsUbiquitin-Protein LigasesMouseOocytePreimplantation embryoProteomeTEAD4TRIM21Trophectoderm

Identifiers

PMID31638890
PMCPMC6805607
OpenAlexW2981861857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.